GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AcipHex® | E-3810 | Pariet®
rabeprazole is an approved drug (FDA (1999))
Compound class:
Synthetic organic
Comment: Rabeprazole is a proton pump inhibitor. This compound is a prodrug which is converted into the active sulphenamide form in the acid environment of the parietal cells.
Marketed formulations may contain rabeprazole sodium (PubChem CID 14720269). View more information in the IUPHAR Pharmacology Education Project: rabeprazole |
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
| Rabeprazole irreversibly inhibits the gastric potassium-transporting ATPase. This proton pump is responsible for secreting H+ ions into the stomach, creating acidic pH. View further gene and protein details for the transporter subunits on the H+/K+-ATPases page. |
External links ![]() |
|
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com |